BioWorld MedTech

Jan. 28, 2010

Prostate cancer treatments vary at county vs. private hospitals

Researchers at Moores Cancer Center at the University of California, San Diego (UCSD) and colleagues have found that prostate cancer treatments varied significantly between county hospitals and private providers. (Medical Device Daily) Read More

Halt's fibroid device, procedure to make other treatments 'irrelevant'

International report: Varian Medical certified to assemble X-ray tubes in China

BrandWatch develops marker to spot counterfeit devices

Washington roundup: Prior FDA move on drug tests opposed by Congress and DEA

Today's MDD food for med-tech thought

Financings roundup: HeartWare seeks to raise $50M in public offering of 1.5M shares

Agreements/contracts: Opsens' sensor tech integrated with Abiomed's heart pump

Patent watch: Neurologix gains protection for Parkinson's disease tech

Deals roundup: Imagine Media signs non-binding letter of intent to acquire DMI

Grants roundup: GE gets $3.27M to bring medical imaging to undeveloped countries

Med-Tech Notes

Product Briefs

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for June 18, 2026.

News in brief

BioWorld Asia

BioWorld Asia briefs for June 16, 2026

GLP-1s need technologies for long-term use

BioWorld

For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...

UTRN gene involved in arthrogryposis, study finds

BioWorld Science

Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...

HMNC raises $50M series B to prep depression drugs for phase III

BioWorld

HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...